2018 state election priorities
Health industry priorities for Victoria Victoria is the state that will change the future of health. The health industry is the industrial sector that encompasses biotechnology, medical technology, pharmaceuticals and digital healthcare that enables research and development as…
Calls to back the health industry for Victoria’s future
BioMelbourne Network is challenging state election candidates to adopt initiatives that make the health industry a top economic priority for Victoria.
Joint statement: The health industry as an economic priority for Victoria
September 2018 Victoria has world-leading competitive advantages in the health industry, which encompasses health and medical research, biotechnology, medical technology, pharmaceuticals, digital health, healthcare delivery, global health and health services. Victoria’s healthcare sector contributes to more than $30…
Invention, connection, trust – key ingredients for curating innovation communities
BioMelbourne Network and The Royal Society of Victoria recently hosted the BioBreakfast Curating Innovation Communities featuring the recipients of the 2018 Women in Leadership Awards. One of our volunteers, Aleisha Symon, wrote the following summary of the event. Aleisha is…
Immutep enters into clinical trial collaboration and supply agreement with Merck KGaA, Darmstadt, Germany, and Pfizer
Immutep Limited is pleased to announce that it has entered into a clinical trial collaboration and supply agreement with Merck KGaA, Darmstadt, Germany and Pfizer Inc., to evaluate the combination of Immutep’s lead immunotherapy product candidate eftilagimod alpha…
Burnet’s qDOS Lab a new approach to bringing innovative technologies to market
Fast-tracking innovative technologies through early proof-of-concept and feasibility stages is a key aim of Burnet Institute’s new initiative, the Quick Development of Solutions Lab (qDOS Lab). Nurturing technologies through key early-stage development phases by adopting a market led approach is a primary focus…
MedTech’s Got Talent 2018 – applications now open
Australia’s premier early stage MedTech challenge is seeking Australia’s aspiring next generation MedTech entrepreneurs and innovators. Now in its fifth and largest year, MedTech’s Got Talent has opened its 2018 application round. Top teams win a share in over…
What to do when an R&D tax incentive claim goes bad
The R&D tax incentive program is the Government’s largest program designed to support business innovation. It has been reviewed multiple times, with each review concluding it provides significant benefits to the Australian economy, far beyond the cost. AusIndustry…
Location, location, translation: key messages from the Biotech Development Lab
Last Friday, BioMelbourne Network hosted the Molecules, Medicines and Markets Biotech Development Lab. One of our volunteers, Emma Wanicek, wrote the following summary of the event. Emma is a Research Assistant in the HIV Neuropathogenesis Laboratory in the Chronic Infectious and…
Sienna appoints exclusive distribution partner for mainland China
Sienna Cancer Diagnostics Ltd has appointed Shaanxi GaoYuan In Vitro Diagnostic Reagents Co. (“GaoYuan”) as the Company’s exclusive distribution partner for mainland China. The distribution agreement for mainland China is a milestone in Sienna’s geographical expansion strategy. The agreement…
Immutep TACTI-mel patient recruitment completed, operational update & Canadian IMP731 patent
Immutep today reports in its operational update that the final patient in Part B of the ongoing TACTI-mel Phase I clinical trial in Australia has now been recruited and is receiving treatment. Patients will be treated for up…
BioMelbourne Network submission regarding R&D Tax Incentive
August 2018 On behalf of the members, BioMelbourne Network has made a submission to Treasury regarding the proposed changes to the R&D Tax Incentive. In terms of our overall consideration of the proposed changes to the R&D Tax…
